Author Interviews, Lifestyle & Health, PNAS, Psychological Science, University Texas / 31.07.2019

MedicalResearch.com Interview with: John M. Griffin PhD James A. Elkins Centennial Chair in Finance McCombs School of Business The University of Texas MedicalResearch.com: What is the background for this study? What are the main findings? Response: The importance of personal traits compared to context for predicting behavior is a long-standing issue in psychology. Yet, we have limited evidence of how predictive personal conduct, such as marital infidelity, is for professional conduct. We use data on usage of a marital infidelity website as a measure of marital infidelity and find that it is strongly correlated with professional conduct in four different professional settings. (more…)
Author Interviews, OBGYNE / 06.04.2019

MedicalResearch.com Interview with: Sarah Baum, MPH investigator at the Texas Policy Evaluation Project Associate at Ibis Reproductive Health MedicalResearch.com: What is the background for this study? Response: Before 2013, use of medication abortion in Texas mirrored national trends, which have steadily increased since the approval of mifepristone--one of the two medications used for medication abortion--in 2000. However, House Bill 2 (HB 2), which was implemented on November 1, 2013, imposed restrictions on medication abortion and required providers to follow the outdated mifepristone label. HB 2 reduced the gestational age limit to 49 days and generally required four visits. On March 29, 2016, the US Food and Drug Administration (FDA) approved a revised label for Mifeprex® (mifepristone 200 mg) that reflected evidence-based practice, which essentially nullified the medication abortion restrictions in HB 2. The label change brought medication abortion prescribing guidelines in line with evidence-based practice, reducing the number of required in-person visits from four to two and extending the period when patients can take the pill from seven weeks of pregnancy to 10 weeks. (more…)